World Vaccine Congress 2017, Barcelona

Eurocine Vaccines will be in place to meet vaccine professionals from industry, academia, non-profit organizations and government to discuss challenges and successes but also present the latest news about our technology plattform Endocine™ and the latest results from the study made  with product candidate Immunose™ FLU. Date and time for the presentation will be announced later.

More information can be found at:

We welcome invitation to book meetings. PLease contat either CSO Anna-Karin Maltais or CEO Hans Arwidsson.


Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases and Stories.

Start your subscription here »